Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analysts Provide Mixed Ratings and Price Targets for Pactiv Evergreen

Elaine Mendonca by Elaine Mendonca
March 4, 2024
in Breaking News
0
Finances (2)
0
SHARES
5
VIEWS
Share on FacebookShare on Twitter

On March 4, 2024, Goldman Sachs analyst Adam Samuelson reiterated a Neutral rating on Pactiv Evergreen (NASDAQ: PTVE) and raised the price target to $14, up from $12.5. This adjustment marks a series of updates that have seen the price target climb from $11 to $12.5 previously.

Other analysts have also weighed in on PTVE, offering a range of price targets. The average among them is $16.58, with the highest forecast coming in at $19.00. Baird analyst Ghansham Panjabi has similarly maintained a Neutral rating on PTVE, but has upped the price target to $12.

[bs_slider_forecast ticker=”PTVE”]

PTVE Stock Price Plummets by 10%: What Investors Need to Know

On March 4, 2024, PTVE stock experienced a significant drop in price, closing at $13.26, a decrease of $1.49 or 10.10% from the previous market close. Furthermore, in pre-market trading, the stock dropped an additional $0.25.

Investors who were holding PTVE shares may have been taken aback by this sudden drop in price. It is important to note that stock prices can be influenced by a variety of factors, including market conditions, company performance, and investor sentiment. In this case, it appears that something may have caused investors to sell off their PTVE shares, leading to the sharp decline in price.

For investors considering buying or selling PTVE stock, it is essential to conduct thorough research and analysis to understand the reasons behind the price drop and determine whether it is a temporary dip or a sign of more significant issues with the company. Keeping an eye on market trends and news related to PTVE can help investors make informed decisions about their investments.

Currently Playing

PTVE Stock Reports Mixed Performance in Financial Results for 2024: Revenue and Net Income Decrease

On March 4, 2024, PTVE stock experienced a mixed performance as the company reported its financial results for the past year and the fourth quarter. According to data from CNN Money, PTVE’s total revenue for the year was $5.51 billion, which represented a decrease of 11.41% compared to the previous year. The total revenue for the fourth quarter was $1.27 billion, which remained flat compared to the previous quarter. PTVE reported a loss of $223.00 million for the year, which was a significant decrease of 170.13% compared to the previous year. The net income for the fourth quarter was $21.00 million, which also decreased by 22.22% compared to the previous quarter. Earnings per share (EPS) for PTVE were reported at -$1.26 for the year, representing a decrease of 171.4% compared to the previous year. The EPS for the fourth quarter was $0.11, which remained flat compared to the previous quarter. Overall, PTVE’s financial performance on March 4, 2024, showed a decrease in total revenue and net income compared to the previous year. However, the company was able to maintain its total revenue and net income at the same level compared to the previous quarter. The decrease in EPS for the year was significant, but the EPS for the fourth quarter remained stable. Investors and analysts will likely closely monitor PTVE’s future financial performance to assess the company’s ability to rebound from the recent declines and drive growth in the coming quarters. It will be crucial for PTVE to implement strategic measures to improve its financial metrics and regain investor confidence in the stock.

[stock_market_chart symbol=”PTVE” range=”3mo” interval=”1d” settings='{“primaryChartType”:”smoothedLine”,”secondaryChartType”:”column”,”width”:”100%”,”height”:”500px”,”marginTop”:0,”marginBottom”:0,”marginLeft”:10,”marginRight”:10,”primaryPanelTitle”:”Price”,”secondaryPanelTitle”:”Volume”,”fontSize”:14,”color”:”#383838″,”primaryLineColor”:”#5679ff”,”primaryLineColorAlpha”:0.15,”secondaryLineColor”:”#5679ff”,”secondaryLineColorAlpha”:0.15,”backgroundColor”:”#fff”,”gridColor”:”#e0e0e0″,”gridAlpha”:0.8,”cursorColor”:”#020202″,”cursorAlpha”:0.8,”scrollbarBackgroundColor”:”#e8e8e8″,”scrollbarSelectedBackgroundColor”:”#f7f7f7″,”scrollbarGraphFillColor”:”#435dc2″,”scrollbarSelectedGraphFillColor”:”#92a8fc”,”primaryLineThickness”:2,”secondaryLineThickness”:1,”gridThickness”:1,”precision”:2,”thousandsSeparator”:”,”,”decimalSeparator”:”.”,”usePrefixes”:false,”searchMode”:”search”,”mouseWheelZoomEnabled”:false,”cursorEnabled”:true,”exportEnabled”:true,”scrollbarEnabled”:true,”legendEnabled”:true,”periods”:”1D,1M,YTD,ALL”,”defaultPeriod”:”1M”}’]

Tags: PTVE
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Markets and money

Financial Performance of Jasper Therapeutics for the Year Ending December 31 2023

Finance_ projections

Financial Analysts Bullish on Li Auto Stock

Redefining Success: How Franchises Adapt to Economic Shifts and Market Demands

Lyfts Stock Rises After Upgrade from RBC Capital

Recommended

XRP Stock

XRP Faces Resistance as Rally Attempt Falters

2 months ago
Insurance company Stock Bull Market

Analyst Expresses Optimism Towards Travelers Companies and Allstate

2 years ago
Rheinmetall Stock

German Defense Giant Rheinmetall Poised for Major Air Defense Contract

4 months ago
Finance_Capitalistic

Top Stock Picks and Performance Analysis on CNBCs Halftime Report Final Trades

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Camping World’s New Leadership Faces First Major Test

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

Diginex Enters Critical Implementation Phase Following Strategic Moves

Deluxe Stock Gains Momentum on Successful Fintech Transition

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Trending

Boston Omaha Stock
Analysis

Investors Await March Report for Boston Omaha’s Strategic Direction

by SiterGedge
February 7, 2026
0

With no recent corporate announcements influencing its share price, market attention has shifted decisively to the upcoming...

Universal Insurance Stock

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

February 7, 2026
Embecta Stock

Embecta’s Q1 Performance Outpaces Analyst Forecasts

February 7, 2026
Camping World Stock

Camping World’s New Leadership Faces First Major Test

February 7, 2026
Viking Therapeutics Stock

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Investors Await March Report for Boston Omaha’s Strategic Direction
  • Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds
  • Embecta’s Q1 Performance Outpaces Analyst Forecasts

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com